Radioactive Iodine Treatment for Thyroid Cancer Complicated by Lacrimal Sac Retention of Iodine
2024

Radioactive Iodine Treatment for Thyroid Cancer Complicated by Lacrimal Sac Retention of Iodine

Sample size: 1 publication Evidence: low

Author Information

Author(s): Suresh Annu, Esposito Giuseppe, Davidson Bruce, Doroslovački Pavle, Jonklaas Jacqueline

Primary Institution: Medstar Georgetown University Hospital

Hypothesis

Can a treatment protocol involving eye drops and lacrimal irrigation mitigate complications from radioactive iodine treatment in patients with nasolacrimal duct stenosis?

Conclusion

The patient was able to undergo treatment for her papillary thyroid cancer and retained full function of her eye despite complications.

Supporting Evidence

  • The patient had increased retention of iodine in the medial portion of her left orbit, suggesting nasolacrimal duct stenosis.
  • Despite complications, the patient retained full function of her eye after treatment.
  • The case highlights the importance of diagnostic scans in identifying potential complications before treatment.

Takeaway

A woman with thyroid cancer had a problem with her tear duct that made it hard for her eyes to clear a special medicine. Doctors helped her by using eye drops and flushing her tear duct, and she was able to keep her eye healthy.

Methodology

The patient received pretreatment with azelastine and prednisolone drops, underwent radioactive iodine treatment, and had saline lacrimal irrigation.

Limitations

The treatment regimen was only applied to one patient without a comparator, making it difficult to confirm its effectiveness.

Participant Demographics

A 48-year-old woman with intermediate-risk papillary thyroid cancer and a history of Graves disease, polycystic ovary syndrome, and Ehlers-Danlos syndrome.

Digital Object Identifier (DOI)

10.1210/jcemcr/luae234

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication